Connect with us

Hi, what are you looking for?

Jewish Business News

Syndicated

Ozgene introduces goGermline technology

Ozgene, a leading provider of genetically modified mice for medical research, has developed goGermline, a new technology to generate knockout and knock-in mice.

Ozgene, a leading provider of genetically modified mice for medical research, has developed goGermline, a new technology to generate knockout and knock-in mice.

Online PR News – 20-August-2014 – Ozgene, a leading provider of genetically modified mice for medical research, has developed a new technology called goGermline. This technology produces genetically modified mice faster, more efficiently and with significantly fewer animals. As such, goGermline has a major positive impact on animal welfare within knockout and knock-in mouse model production. This new technology is part of Ozgenes overall mission to advance humanity – inspire curiosity.

Traditionally, genetic modification is done in mouse embryonic stem cells (ESC) from which a chimeric mouse is created. When mated, a percentage of the chimeric offspring are from the modified ESC that carry the genetic modification. However, this also inevitably produces mice that are not ESC derived and therefore unnecessary.

goGermline technology addresses this issue by generating only the ESC offspring, with significantly less unnecessary mice being produced. goGermline has a number of benefits. From an animal welfare point of view it improves the three Rs (Replace, Reduce, Refine). From a researchers point of view it improves production timelines and efficiencies in making knockout and knock-in mouse models.

For more information regarding goGermline technology, please contact Ozgene by visiting www.ozgene.com/goGermline

About the company: Ozgene is a global provider of custom designed knockout, knock-in and transgenic mice, with a demonstrated track record of successful mouse model generation, specialising in C57BL/6 strain. Ozgene has over two decades of experience in the field, and more than 250 research papers have been published using Ozgene mice.

Company Contact Information
Mr Eddie Noonan
http://www.ozgene.com/goGermline
+61 8 9212 2200
 
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

Business

Now Platika joins and elite club of $10 billion plus Israeli firms.

Advertisement